Concepedia

Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae

Violet Leibman, Emily T. Martin, Ruthy Tal-Jasper, Leonti Grin, Kayoko Hayakawa, Coral Shefler, Tal Azouri, Tamir Kaplansky, Moran Maskit, Tsilia Lazarovitch,

Annals of Clinical Microbiology and Antimicrobials · 2015 · 22 citations · 8 references

DOIFull text

Open access

Abstract

The score's 90% NPV implies it could reduce un-necessary (and toxic) empiric use of anti-CRE therapeutics, but this should be studied prospectively and on broader populations in order to test its potential role in reducing mortality.

References

8

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

Samira M. Garonzik, Jian Li, Visanu Thamlikitkul et al. · Antimicrobial Agents and Chemotherapy · 2011 · 679 citations · Full text

A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

Ronen Ben‐Ami, Jesús Rodríguez‐Baño, Hande Arslan et al. · Clinical Infectious Diseases · 2009 · 455 citations · Full text

Attributable Mortality Rate for Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bacteremia

Abraham Borer, Lisa Saidel‐Odes, Klaris Riesenberg et al. · Infection Control and Hospital Epidemiology · 2009 · 381 citations

Carbapenem-Resistant Enterobacteriaceae

Mitchell J. Schwaber, Yehuda Carmeli · JAMA · 2008 · 296 citations

Colistin-Resistant, Klebsiella pneumoniae Carbapenemase (KPC)-Producing Klebsiella pneumoniae Belonging to the International Epidemic Clone ST258

Tatiana Bogdanovich, Jennifer Adams‐Haduch, Guo‐Bao Tian et al. · Clinical Infectious Diseases · 2011 · 150 citations · Full text

, , +15